Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Electrostimulation Study for Ocular Graft vs. Host Disease

NCT: NCT07166848 · ENROLLING_BY_INVITATION

NCT IDNCT07166848
StatusENROLLING_BY_INVITATION
Start Date2025-11-30
Completion2029-11-30
SponsorZhonghui K. Luo, MD, PhD (OTHER)
First posted
Last updated

Brief Summary

This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

Frequently Asked Questions

What is Electrostimulation Study for Ocular Graft vs. Host Disease?

Electrostimulation Study for Ocular Graft vs. Host Disease is a clinical trial registered under NCT07166848. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07166848?

The current status of NCT07166848 (Electrostimulation Study for Ocular Graft vs. Host Disease) is: ENROLLING_BY_INVITATION.

When did Electrostimulation Study for Ocular Graft vs. Host Disease start?

Electrostimulation Study for Ocular Graft vs. Host Disease started on 2025-11-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.